|
US4032526A
(en)
|
1975-10-02 |
1977-06-28 |
American Cyanamid Company |
1,2-dimethyl-3 or 5-piperazinyl-pyrazolium salts
|
|
US4426382A
(en)
|
1980-02-13 |
1984-01-17 |
Sankyo Company Limited |
4-Amino-6,7-dimethoxy-2-piperazinylquinazoline derivatives, their preparation and use
|
|
DE3517617A1
(de)
|
1985-05-15 |
1986-11-20 |
Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München |
Neue pyridaziniumverbindungen, verfahren zu deren herstellung und diese enthaltende fungizide und algizide mittel
|
|
ES8802151A1
(es)
|
1985-07-31 |
1988-04-01 |
Janssen Pharmaceutica Nv |
Un procedimiento para la preparacion de nuevos piridazinaminas.
|
|
JPS6319745Y2
(2)
|
1985-11-07 |
1988-06-01 |
|
|
|
JPS61165445A
(ja)
|
1986-01-08 |
1986-07-26 |
株式会社巴組鐵工所 |
振動を減少しうる床構造
|
|
US5096916A
(en)
|
1990-05-07 |
1992-03-17 |
Aegis Technology, Inc. |
Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline
|
|
DE69325662T2
(de)
|
1992-10-23 |
2000-02-10 |
Merck Sharp & Dohme Ltd., Hoddesdon |
Dopamin rezeptor subtyp liganden
|
|
JP3166376B2
(ja)
|
1993-02-03 |
2001-05-14 |
松下電器産業株式会社 |
熱利用装置
|
|
US5629235A
(en)
|
1995-07-05 |
1997-05-13 |
Winbond Electronics Corporation |
Method for forming damage-free buried contact
|
|
TW531537B
(en)
|
1995-12-27 |
2003-05-11 |
Janssen Pharmaceutica Nv |
1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives
|
|
US5629325A
(en)
|
1996-06-06 |
1997-05-13 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
|
|
US6437138B1
(en)
|
1996-06-06 |
2002-08-20 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
|
|
US6979686B1
(en)
|
2001-12-07 |
2005-12-27 |
Pharmacia Corporation |
Substituted pyrazoles as p38 kinase inhibitors
|
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
|
US6670222B1
(en)
*
|
1997-06-14 |
2003-12-30 |
Jds Uniphase Corporation |
Texturing of a die pad surface for enhancing bonding strength in the surface attachment
|
|
EE04588B1
(et)
|
1997-10-27 |
2006-02-15 |
Neurosearch A/S |
Heteroarüüldiasatsükloalkaanid kui atsetüülkoliini nikotiinretseptorite kolinergilised ligandid, nende kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
|
|
US6143892A
(en)
|
1998-11-20 |
2000-11-07 |
G. D. Searle & Co. |
Process for making 5-substituted pyrazoles
|
|
US6248755B1
(en)
|
1999-04-06 |
2001-06-19 |
Merck & Co., Inc. |
Pyrrolidine modulators of chemokine receptor activity
|
|
SK287418B6
(sk)
|
1999-05-04 |
2010-09-07 |
Schering Corporation |
Farmaceutický prípravok s obsahom CCR5 antagonistov a súprava s obsahom tohto prípravku
|
|
US20020045613A1
(en)
|
2000-04-27 |
2002-04-18 |
Heinz Pauls |
1-aroyl-piperidinyl benzamidines
|
|
OA12274A
(en)
|
2000-05-22 |
2006-05-09 |
Aventis Pharma Inc |
Arylmethylamine derivatives for use as tryptase inhibitors.
|
|
WO2003037271A2
(en)
|
2001-10-30 |
2003-05-08 |
Millennium Pharmaceuticals,Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
US6806279B2
(en)
|
2001-12-17 |
2004-10-19 |
Sunesis Pharmaceuticals, Inc. |
Small-molecule inhibitors of interleukin-2
|
|
EP1474401A2
(en)
|
2002-02-05 |
2004-11-10 |
Novo Nordisk A/S |
Novel aryl- and heteroarylpiperazines
|
|
JP2003240776A
(ja)
|
2002-02-13 |
2003-08-27 |
Horiba Ltd |
クロマトグラフリーダを用いる測定方法およびそれに用いる試験片ホルダ並びにクロマトグラフリーダを用いる検査／測定装置
|
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
|
US20030195192A1
(en)
|
2002-04-05 |
2003-10-16 |
Fortuna Haviv |
Nicotinamides having antiangiogenic activity
|
|
CN100445276C
(zh)
|
2002-03-13 |
2008-12-24 |
詹森药业有限公司 |
用作组蛋白去乙酰酶抑制剂的磺酰基衍生物
|
|
US20040014744A1
(en)
|
2002-04-05 |
2004-01-22 |
Fortuna Haviv |
Substituted pyridines having antiangiogenic activity
|
|
US20050245537A1
(en)
|
2002-04-24 |
2005-11-03 |
Noboru Tsuchimori |
Use of compounds having ccr antagonism
|
|
EP1501507B1
(en)
|
2002-04-29 |
2008-05-28 |
Merck & Co., Inc. |
Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
|
|
TW200400960A
(en)
|
2002-06-05 |
2004-01-16 |
Pharmacia Corp |
Novel pyrazoles and their use as P38 kinase inhibitors
|
|
AU2003270199A1
(en)
|
2002-09-13 |
2004-04-30 |
Glaxo Group Limited |
Urea compounds active as vanilloid receptor antagonists for the treatment of pain
|
|
GB0229618D0
(en)
|
2002-12-19 |
2003-01-22 |
Cancer Rec Tech Ltd |
Pyrazole compounds
|
|
US20040147561A1
(en)
|
2002-12-27 |
2004-07-29 |
Wenge Zhong |
Pyrid-2-one derivatives and methods of use
|
|
WO2004074438A2
(en)
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Ccr8 antagonists
|
|
PL1633724T3
(pl)
|
2003-03-12 |
2011-10-31 |
Kudos Pharm Ltd |
Pochodne ftalazynonu
|
|
CA2523431A1
(en)
|
2003-04-23 |
2004-11-25 |
Glaxo Group Limited |
Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
|
|
FR2854158B1
(fr)
|
2003-04-25 |
2006-11-17 |
Sanofi Synthelabo |
Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique
|
|
JP2006528147A
(ja)
|
2003-07-18 |
2006-12-14 |
グラクソ グループ リミテッド |
ヒスタミンｈ３受容体リガンドとしての置換ピペリジン
|
|
WO2005009976A1
(en)
|
2003-07-29 |
2005-02-03 |
Novo Nordisk A/S |
Pyridazinyl- piperazines and their use as histamine h3 receptor ligands
|
|
KR20080052683A
(ko)
|
2003-12-18 |
2008-06-11 |
인사이트 코포레이션 |
케모킨 수용체의 조절제로서의3-사이클로알킬아미노피롤리딘 유도체
|
|
GB0403155D0
(en)
|
2004-02-12 |
2004-03-17 |
Vernalis Res Ltd |
Chemical compounds
|
|
US7435830B2
(en)
|
2004-03-03 |
2008-10-14 |
Chemocentryx, Inc. |
Bicyclic and bridged nitrogen heterocycles
|
|
PE20060285A1
(es)
|
2004-03-30 |
2006-05-08 |
Aventis Pharma Inc |
Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
|
|
US7423147B2
(en)
|
2004-03-31 |
2008-09-09 |
Janssen Pharmaceutical, N.V. |
Pyridine compounds as histamine H3 modulators
|
|
WO2005117909A2
(en)
|
2004-04-23 |
2005-12-15 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
|
WO2006001958A2
(en)
|
2004-05-21 |
2006-01-05 |
Merck & Co., Inc. |
Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
|
|
CA2569016C
(en)
|
2004-06-02 |
2012-11-27 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound
|
|
FR2871157A1
(fr)
|
2004-06-04 |
2005-12-09 |
Aventis Pharma Sa |
Produits biaryl aromatiques, compositions les contenant et utilisation
|
|
WO2006012135A1
(en)
|
2004-06-24 |
2006-02-02 |
Janssen Pharmaceutica, N. V. |
Quaternary salt ccr2 antagonists
|
|
US8071624B2
(en)
|
2004-06-24 |
2011-12-06 |
Incyte Corporation |
N-substituted piperidines and their use as pharmaceuticals
|
|
WO2006004741A2
(en)
|
2004-06-28 |
2006-01-12 |
Incyte Corporation |
3-aminocyclopentanecarboxamides as modulators of chemokine receptors
|
|
JP2008510783A
(ja)
|
2004-08-26 |
2008-04-10 |
クドス ファーマシューティカルズ リミテッド |
４−ヘテロアリールメチル置換フタラジノン誘導体
|
|
GB0420831D0
(en)
|
2004-09-17 |
2004-10-20 |
Glaxo Group Ltd |
Novel compounds
|
|
AU2005286647A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
|
|
GB0421525D0
(en)
|
2004-09-28 |
2004-10-27 |
Novartis Ag |
Inhibitors of protein kineses
|
|
WO2006038734A1
(en)
|
2004-10-08 |
2006-04-13 |
Astellas Pharma Inc. |
Pyridazinone derivatives cytokines inhibitors
|
|
CA2589106C
(en)
|
2004-11-02 |
2015-07-21 |
Northwestern University |
Pyridazine compounds, compositions and methods and their use in treating inflammatory diseases
|
|
PA8653301A1
(es)
|
2004-11-22 |
2006-11-09 |
Incyte Corp Incyte Corp |
Sales de la n-[2-({(3r)-1-[trans-4-hidroxi-4-(6-metoxipiridin-3-il) ciclohexil)pirrolidin
|
|
DE102004061751A1
(de)
|
2004-12-22 |
2006-07-06 |
Bayer Healthcare Ag |
Cyanoguanidin-substituierte Pyrazoline
|
|
TWI385164B
(zh)
|
2005-02-17 |
2013-02-11 |
Astellas Pharma Inc |
Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivatives (II)
|
|
US20060235028A1
(en)
|
2005-04-14 |
2006-10-19 |
Li James J |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
|
|
JP2008537953A
(ja)
|
2005-04-15 |
2008-10-02 |
エラン ファーマシューティカルズ，インコーポレイテッド |
ブラジキニンｂ１受容体拮抗作用に有用な新規化合物
|
|
TW200716594A
(en)
|
2005-04-18 |
2007-05-01 |
Neurogen Corp |
Substituted heteroaryl CB1 antagonists
|
|
EP2354140A1
(en)
|
2005-05-20 |
2011-08-10 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyridines useful as inhibitors of protein kinase
|
|
MX2007015675A
(es)
|
2005-07-04 |
2008-02-20 |
Novo Nordisk As |
Antagonistas del receptor de histamina h3.
|
|
US7851474B2
(en)
|
2005-08-02 |
2010-12-14 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
|
GB0517184D0
(en)
|
2005-08-22 |
2005-09-28 |
Glaxo Group Ltd |
Compounds
|
|
AR055203A1
(es)
|
2005-08-31 |
2007-08-08 |
Otsuka Pharma Co Ltd |
Derivados de benzotiofeno con propiedades antipsicoticas
|
|
TW200800999A
(en)
|
2005-09-06 |
2008-01-01 |
Astrazeneca Ab |
Novel compounds
|
|
KR101415426B1
(ko)
|
2005-09-27 |
2014-07-04 |
아이알엠 엘엘씨 |
디아릴아민-함유 화합물 및 조성물, 및 ｃ-ｋｉｔ 수용체의조절제로서의 그의 용도
|
|
JO2769B1
(en)
|
2005-10-26 |
2014-03-15 |
جانسين فارماسوتيكا ان. في |
Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
|
|
US8067457B2
(en)
|
2005-11-01 |
2011-11-29 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of CCR2
|
|
WO2007053495A2
(en)
|
2005-11-01 |
2007-05-10 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of ccr2
|
|
CN101309915A
(zh)
|
2005-11-14 |
2008-11-19 |
Irm责任有限公司 |
作为lxr调节剂的化合物和组合物
|
|
AU2006329007A1
(en)
|
2005-12-20 |
2007-06-28 |
Novartis Ag |
Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
|
|
IL172838A
(en)
|
2005-12-27 |
2010-06-16 |
Joma Int As |
Methods for production of metal oxide nano particles with controlled properties and nano particles and preparations produced thereby
|
|
WO2007084868A2
(en)
|
2006-01-17 |
2007-07-26 |
Kalypsys, Inc. |
Treatment of disorders by activation of the unfolded protein response
|
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
NZ570847A
(en)
|
2006-02-28 |
2011-10-28 |
Helicon Therapeutics Inc |
Therapeutic compounds
|
|
WO2007105058A2
(en)
|
2006-03-16 |
2007-09-20 |
Pfizer Products Inc. |
Pyrazole compounds
|
|
WO2007120574A2
(en)
|
2006-04-11 |
2007-10-25 |
Merck & Co., Inc. |
Diaryl substituted alkanes
|
|
US7807671B2
(en)
|
2006-04-25 |
2010-10-05 |
Bristol-Myers Squibb Company |
Diketo-piperazine and piperidine derivatives as antiviral agents
|
|
US20100168120A1
(en)
|
2006-04-28 |
2010-07-01 |
Neuromedix Inc. |
Salts of pyridazine compounds
|
|
US20080039450A1
(en)
|
2006-06-22 |
2008-02-14 |
Jensen Annika J |
Compounds
|
|
CA2657247A1
(en)
|
2006-07-28 |
2008-01-31 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the cb2 receptor
|
|
GB0617575D0
(en)
|
2006-09-06 |
2006-10-18 |
Syngenta Ltd |
Herbicidal compounds and compositions
|
|
US7928123B2
(en)
|
2006-09-25 |
2011-04-19 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the CB2 receptor
|
|
CN101534824A
(zh)
|
2006-11-17 |
2009-09-16 |
艾博特公司 |
作为化学活素受体拮抗剂的氨基吡咯烷
|
|
ES2548353T3
(es)
|
2006-12-28 |
2015-10-15 |
Abbvie Inc. |
Inhibidores de poli(ADP-ribosa)polimerasa
|
|
CA2676715A1
(en)
|
2007-02-12 |
2008-08-21 |
Merck & Co., Inc. |
Piperazine derivatives for treatment of ad and related conditions
|
|
JP4785881B2
(ja)
|
2007-02-27 |
2011-10-05 |
大塚製薬株式会社 |
医薬
|
|
FR2915552B1
(fr)
|
2007-04-27 |
2009-11-06 |
Technip France |
Conduite tubulaire flexible pour le transport d'hydrocarbures gazeux.
|
|
JP5603770B2
(ja)
|
2007-05-31 |
2014-10-08 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃｃｒ２受容体拮抗薬およびその使用
|
|
CA2691662A1
(en)
|
2007-07-02 |
2009-01-08 |
F. Hoffmann-La Roche Ag |
Imidazole derivatives as ccr2 receptor antagonists
|
|
US7977358B2
(en)
|
2007-07-26 |
2011-07-12 |
Hoffmann-La Roche Inc. |
Pyrazol derivatives
|
|
MX2010002005A
(es)
|
2007-08-22 |
2010-03-11 |
Irm Llc |
Derivados de 2-heteroaril-amino-pirimidina como inhibidores de cinasa.
|
|
RU2010116821A
(ru)
|
2007-10-01 |
2011-11-10 |
Ф.Хоффманн-Ля Аг (Ch) |
N-гетероциклические биарильные карбоксамиды в качестве антагонистов рецептора ccr
|
|
CN101820789A
(zh)
|
2007-10-12 |
2010-09-01 |
黄钟午 |
鞋带捆绑工具
|
|
US20090131417A1
(en)
|
2007-11-20 |
2009-05-21 |
Letavic Michael A |
Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
|
|
WO2009066084A1
(en)
|
2007-11-21 |
2009-05-28 |
F. Hoffmann-La Roche Ag |
2 -morpholinopyrimidines and their use as pi3 kinase inhibitors
|
|
US8829006B2
(en)
|
2007-11-22 |
2014-09-09 |
Boehringer Ingelheim International Gmbh |
Compounds
|
|
EP2062889A1
(de)
|
2007-11-22 |
2009-05-27 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Verbindungen
|
|
AU2009259496A1
(en)
|
2008-06-18 |
2009-12-23 |
F. Hoffmann-La Roche Ag |
Novel heteroaryl carboxamide derivatives
|
|
JP5693452B2
(ja)
|
2008-08-04 |
2015-04-01 |
シーエイチディーアイ ファウンデーション，インコーポレーテッド |
特定のキヌレニン−３−モノオキシゲナーゼインヒビター、医薬組成物およびそれらの使用方法
|
|
GB0815369D0
(en)
|
2008-08-22 |
2008-10-01 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
|
AU2009289378A1
(en)
|
2008-09-02 |
2010-03-11 |
Boehringer Ingelheim International Gmbh |
Novel benzamides, production thereof, and use thereof as medicaments
|
|
CA2737639A1
(en)
|
2008-09-25 |
2010-04-01 |
Boehringer Ingelheim International Gmbh |
Compounds which selectively modulate the cb2 receptor
|
|
CN102256963B
(zh)
|
2008-12-19 |
2014-06-11 |
贝林格尔.英格海姆国际有限公司 |
作为ccr2受体拮抗剂用于治疗炎症、哮喘和copd的环状嘧啶-4-甲酰胺
|
|
US20110301143A1
(en)
|
2009-02-23 |
2011-12-08 |
Elise Isabel |
Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
ES2674275T3
(es)
*
|
2009-12-17 |
2018-06-28 |
Centrexion Therapeutics Corporation |
Antagonistas del receptor CCR2 y usos de los mismos
|
|
EP2513086B1
(en)
|
2009-12-17 |
2015-04-29 |
Boehringer Ingelheim International GmbH |
Novel antagonists for ccr2 and uses thereof
|
|
US8329735B2
(en)
|
2010-03-05 |
2012-12-11 |
Boehringer Ingelheim International Gmbh |
Tetrazole compounds which selectively modulate the CB2 receptor
|
|
WO2011141474A1
(en)
|
2010-05-12 |
2011-11-17 |
Boehringer Ingelheim International Gmbh |
Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
|
|
JP5646736B2
(ja)
|
2010-05-12 |
2014-12-24 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規ｃｃｒ２受容体アンタゴニスト、これらの製造方法、及び薬物としてのこれらの使用
|
|
WO2011144501A1
(en)
|
2010-05-17 |
2011-11-24 |
Boehringer Ingelheim International Gmbh |
Ccr2 antagonists and uses thereof
|
|
WO2011147772A1
(en)
|
2010-05-25 |
2011-12-01 |
Boehringer Ingelheim International Gmbh |
Ccr2 receptor antagonists
|
|
US8962656B2
(en)
|
2010-06-01 |
2015-02-24 |
Boehringer Ingelheim International Gmbh |
CCR2 antagonists
|
|
WO2012171863A1
(en)
|
2011-06-16 |
2012-12-20 |
Boehringer Ingelheim International Gmbh |
New selective ccr2 antagonists
|
|
EP2731941B1
(en)
|
2011-07-15 |
2019-05-08 |
Boehringer Ingelheim International GmbH |
Novel and selective ccr2 antagonists
|
|
JP6229575B2
(ja)
|
2014-03-31 |
2017-11-15 |
京セラドキュメントソリューションズ株式会社 |
画像処理装置
|
|
PT3317270T
(pt)
|
2015-07-02 |
2020-08-24 |
Centrexion Therapeutics Corp |
(4-((3r,4r)-3-metoxitetrahidro-pirano-4-ilamino)piperidina-1-il)(5-metil-6-(((2r,6s)-6-(p-tolil)tetrahidro-2h-pirano-2-il)metilamino)pirimidina-4-il)citrato de metanona
|